Global Market for Nasopharyngeal Carcinoma Treatment is expected to rise at a CAGR of 5.9% to hit a revenue of US$ 2.1 Billion | Future Market Insights, Inc.
Future Market Insights Global and Consulting Pvt. Ltd.
7 min read
Future Market Insights Global and Consulting Pvt. Ltd.
The nasopharyngeal carcinoma treatment market includes various treatment options such as surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The market is driven by the increasing prevalence of nasopharyngeal carcinoma, the rising demand for effective treatment options, and the growing investments in research and development activities for the development of new therapies.
NEWARK, Del, May 04, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Nasopharyngeal carcinoma treatment market is expected to grow at a value of 5.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Nasopharyngeal carcinoma treatment is expected to rise up to a market valuation of US$ 2.1 Billion. Growth of the market can be attributed to the increasing incidence of NPC, rising healthcare expenditure, and growing research and development activities.
One of the key factors driving the growth of the nasopharyngeal carcinoma treatment market is the increasing prevalence of NPC. According to the World Health Organization, NPC is most common in Southeast Asia and North Africa, where the incidence rate can be as high as 50 cases per 100,000 people. In addition, the incidence of NPC is increasing in other parts of the world, including Europe and North America, due to migration and changing lifestyles.
Another factor driving the market growth is the rising healthcare expenditure, especially in emerging economies. Governments in countries such as China, India, and Brazil are increasing their healthcare spending to improve access to healthcare services and develop better infrastructure. This has resulted in increased investments in cancer research and development, which is expected to drive the growth of the nasopharyngeal carcinoma treatment market.
Moreover, the growing research and development activities in the field of cancer treatment are expected to drive the growth of the nasopharyngeal carcinoma treatment market. Pharmaceutical companies are investing heavily in the development of new drugs and therapies for the treatment of NPC, which is expected to result in better treatment outcomes and improved patient survival rates.
Key Takeaways:
The global Nasopharyngeal carcinoma treatment market is expected to grow with a 5.9% CAGR during 2023 to 2033.
Hospital pharmacies are expected to hold 40% of the market share in 2023 for Nasopharyngeal carcinoma treatment market.
Asia Pacific Nasopharyngeal carcinoma treatment market size is expected to possess 47% market share in 2023.
Middle East and Africa is expected to possess 41% market share for Nasopharyngeal carcinoma treatment market in 2023.
“Increasing prevalence of NPC, rising healthcare expenditure, and growing research and development activities is expected to drive the growth of the market in the upcoming years.” states an analyst at FMI.
Competitive Landscape:
Key players in the nasopharyngeal carcinoma treatment are Pfizer Inc., Sanofi, Merck & Co., Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Cyclacel Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd, CELGENE CORPORATION and BioDiem Ltd
Pfizer has formed partnerships with several academic institutions and other pharmaceutical companies to develop new therapies and drugs for nasopharyngeal carcinoma. These collaborations have led to the development of several promising drugs and therapies that are currently being tested in clinical trials.
Sanofi developed Taxotere (docetaxel), a chemotherapy drug that is used in the treatment of several types of cancer, including nasopharyngeal carcinoma. Taxotere works by disrupting the growth and division of cancer cells, slowing down or stopping the growth of cancer.
More Valuable Insights:
Future Market Insights, in its new offering, presents an unbiased analysis of the global Nasopharyngeal carcinoma treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Drug Class (Ellence, Taxotere, Bleomycin, Methotrexate) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)
Have a Look at Related Reports of the Healthcare domain:
Lab Accessories Market Size: The lab accessories market is anticipated to register a CAGR of 6.8% during the period of 2022 to 2032. The market is anticipated to reach US$ 1.1 Billion in 2032, from US$ 585.0 Million in 2022.
IV Therapy and Vein Access Devices Market Share: Owing to the growing support from various governmental organizations, the market is likely to propel to US$ 44.4 Billion by 2032. The trade is projected at a 5.6% CAGR during the forecast period.
Hard Gelatin Capsules Market Demand: The demand in the hard gelatin capsules market is set to display substantial growth at a CAGR of 6.4% from 2022 to 2032.
Non-Vascular Stents Market Analysis: During the projected timeframe, the non-vascular stents market is predicted to increase at a CAGR of 4.5% (2022 to 2032). The industry is anticipated to be worth US$ 1.21 Billion in 2022, rising to US$ 1.9 Billion by 2032.
Nuclear Medicine Equipment Market Forecast: The nuclear medical equipment market is estimated to grow at a stable CAGR of 4.1% between 2022 and 2032. The market for nuclear medical equipment is expected to expand from US$ 2.3 Billion in 2022 to US$ 3.4 Billion in 2032.
Digital Patient Monitoring Systems Market Trends: The global Digital Patient Monitoring Systems market is estimated at US$ 96.4 Billion in 2022 and is projected to reach a valuation of US$ 470 Billion by 2032.
Women Digital Health Solutions Market Outlook: The global Women Digital Health Solutions Market is estimated at US$ 2.3 Billion in 2022 and is projected to reach a valuation of US$ 20.1 Billion by 2032.
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.
